Biotech

All Articles

Eli Lilly hops deeper in to AI along with $409M Hereditary Leap deal

.Eli Lilly has actually sprung right into an AI-enabled drug breakthrough package, partnering with R...

After FDA turndown and cutbacks, Lykos CEO is actually leaving behind

.Lykos chief executive officer and owner Amy Emerson is walking out, with chief functioning officer ...

Novartis kindles brand new stage of Voyager deal along with $15M capsid bargain

.Novartis levels a brand new outpost in its collaboration along with Voyager Therapies, paying $15 m...

Lilly messages a lot more favorable information on its own regular insulin prospect

.On the heels of an FDA being rejected for its chief rivalrous Novo Nordisk, Eli Lilly is actually p...

IN 8bio stops stage 2 trial, gives up half of workforce

.Simply a couple of months after dosing the first patient in a stage 2 trial for recently detected g...

Lilly, Haya ink $1B biobuck excessive weight treaty to browse black genome

.Eli Lilly's hunt for excessive weight aim ats has led it to the dark genome. The Big Pharma has com...

ArsenalBio elevates $325M, pivots away from past lead property

.Collection Biosciences is moving on up. The tissue treatment provider has added $325 thousand in am...

Lilly- supported weight loss biotech files IPO

.After elevating $170 thousand back in February, metabolic disease-focused BioAge Labs has actually ...

Aelis' marijuana use drug fails phase 2b, steering Indivior to review $100M option

.Aelis Farma's chances of protecting a simple, favorable choice on a $one hundred million choice pay...

ProKidney halts period 3 trial not required for cell treatment approval

.ProKidney has actually stopped one of a pair of stage 3 trials for its own tissue therapy for kidne...